Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma.
Hoda D, Richards R, Faber EA, Deol A, Hunter BD, Weber E, DiFilippo H, Henderson-Clark T, Meaux L, Crivera C, Riccobono C, Garrett A, Jackson CC, Fowler J, Theocharous P, Stewart R, Lorden AL, Porter DL, Berger A.
Hoda D, et al. Among authors: hunter bd.
Future Oncol. 2022 Jun;18(19):2415-2431. doi: 10.2217/fon-2022-0162. Epub 2022 May 18.
Future Oncol. 2022.
PMID: 35583358